// App-Quantinova.ai

3473 : Sub-classification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases

Researchers

Presenter

  • Jie-Fu Chen

Principal Investigators

  • Hao Ho

  • Jake Lichterman

  • Daniel J. Luthringer

  • Jiaoti Huang

  • Ker-Chau Li

  • Leland WK Chung

  • Zunfu Ke

  • Yi-Tsung Lu

  • Yang Zhang

  • Mitch A. Garcia

  • Shang-Fu Chen

  • An-Jou Liang

  • Haiyen E. Zhau

  • Shuang Hou

  • Rafi S. Ahmed

Medical Centers

  • Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

  • Institute of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

  • Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, China

  • Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA

Locations

  • United States

  • China

Companies

  • Molecular Pharmacolo

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Breast cancer

Biomarkers

  • Plasma Renin Activity

  • Circulating tumor cells

Drug/Treatment

  • Mifepristone

  • onapristone

  • Alora

  • ZK230211

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved